JPRN-UMIN000029293Completed未知
Comparison of immunogenicity of monovalent inactivated influenza vaccine contained Saitama strain with it contained Hong Kong strain - Comparison of immunogenicity of monovalent inactivated influenza vaccine contained Saitama strain with it contained Hong Kong strain
SOUSEIKAI Clinical Epidemiological Research Center0 sites100 target enrollmentStarted: September 26, 2017Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 100
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Subjects who; 1. have fever. 2. have sever acute disease 3. are allergic to substance of study vaccine, eggs, chicken, or any derivative of chicken . 4. are vaccinated live vaccine within 27 days, or inactivated vaccine within 6 days. 5. are judged not appropriate for this study by study physician.
Investigators
Similar Trials
Recruiting
Phase 4
Comparing immune response to oral polio vaccine administered at short intervals with vaccine administered at standard intervals in healthy newborns in PakistapoliomyelitisInfection - Other infectious diseasesPublic Health - Other public healthACTRN12612000276853WHO800
Not yet recruiting
Phase 4
Mixing of COVID vaccines studyCTRI/2021/08/035648Christian Medical College
Not yet recruiting
Phase 4
Comparative evaluation of immunogenicity of various schedules and delivery options to provide fractional Dose Inactivated Poliovirus Vaccine in routine immunizatioCTRI/2017/02/007793Panacea Biotec Ltd800
Completed
Not Applicable
Comparative evaluation of Immunogenicity of monovalent type 1 Oral Poliovirus Vaccine (mOPV1) and monovalent type 3 Oral Poliovirus Vaccine (mOPV3) versus trivalent Oral Poliovirus Vaccine (tOPV): a randomised double-blind controlled trial in South AfricaPoliomyelitisInfections and InfestationsISRCTN18107202World Health Organization (WHO) (Switzerland)800
Completed
Not Applicable
Comparative evaluation of immunogenicity of monovalent type 1 oral poliovirus vaccine (mOPV1) versus trivalent OPV (tOPV): a randomised double-blind trial set in EgyptPolioInfections and InfestationsISRCTN76316509World Health Organization (WHO) (Switzerland)600